Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study.

Liu, Yu; Li, Yongzhen; Shen, Tian; Zhang, Huiming; Luo, Shuangyan; Zhang, Qing; Dang, Xiqiang; Li, Xiaoyan; Long, Hai

Liu, Yu; Li, Yongzhen; Shen, Tian; Zhang, Huiming; Luo, Shuangyan; Zhang, Qing; Dang, Xiqiang; Li, Xiaoyan; Long, Hai.

Afiliación

Liu Y; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Li Y; Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Shen T; Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhang H; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Luo S; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhang Q; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Dang X; Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Li X; Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: lixiaoyan001@csu.edu.cn.
Long H; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: dr.hailong@csu.edu.cn.

J Am Acad Dermatol ; 91(3): 524-527, 2024 Sep.

Article en En | MEDLINE | ID: mdl-38697217

Asunto(s)

Anticuerpos Monoclonales Humanizados; Dermatomiositis; Humanos; Dermatomiositis/tratamiento farmacológico; Dermatomiositis/complicaciones; Estudios Retrospectivos; Anticuerpos Monoclonales Humanizados/uso terapéutico; Femenino; Masculino; Niño; Adolescente; Inmunosupresores/uso terapéutico; Índice de Severidad de la Enfermedad; Adulto; Resultado del Tratamiento; Persona de Mediana Edad

Palabras clave

B cell activating factor (BAFF); B lymphocyte stimulator (BLyS); Myositis Intention-to-Treat Activity Index (MITAX); belimumab; dermatomyositis; juvenile dermatomyositis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatomiositis / Anticuerpos Monoclonales Humanizados Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google